Table of Content

Table of Contents

1 Product Introduction and Overview
1.1 Product Definition
1.2 Product Specification
1.3 Global Market Overview
1.3.1 Global Primary Progressive Multiple Sclerosis Treatment Market Status and Forecast (2016-2027)
1.3.2 Global Primary Progressive Multiple Sclerosis Treatment Sales Value CAGR by Region
1.4 Market Drivers, Inhibitors
1.4.1 Market Drivers
1.4.2 Market Inhibitors
1.4.3 COVID-19 Impact Analysis
2 Global Primary Progressive Multiple Sclerosis Treatment Supply by Company
2.1 Global Primary Progressive Multiple Sclerosis Treatment Sales Value by Company
2.2 Primary Progressive Multiple Sclerosis Treatment Sales Area of Main Manufacturers
2.3 Trend of Concentration Rate
3 Global and Regional Primary Progressive Multiple Sclerosis Treatment Market Status by Type
3.1 Primary Progressive Multiple Sclerosis Treatment Type Introduction
3.1.1 ApE
3.1.2 Biotin
3.1.3 GZ-402668
3.1.4 Ibudilast
3.1.5 Idebenone
3.1.6 Laquinimod Sodium
3.1.7 Others
3.2 Global Primary Progressive Multiple Sclerosis Treatment Market by Type
3.3 North America: by Type
3.4 Europe: by Type
3.5 Asia Pacific: by Type
3.6 Central & South America: by Type
3.7 Middle East & Africa: by Type
4 Global and Regional Primary Progressive Multiple Sclerosis Treatment Market Status by Application
4.1 Primary Progressive Multiple Sclerosis Treatment Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Primary Progressive Multiple Sclerosis Treatment Market by Application
4.3 North America: by Application
4.4 Europe: by Application
4.5 Asia Pacific: by Application
4.6 Central & South America: by Application
4.7 Middle East & Africa: by Application
5 Global Primary Progressive Multiple Sclerosis Treatment Market Status by Region
5.1 Global Primary Progressive Multiple Sclerosis Treatment Market by Region
5.2 North America Primary Progressive Multiple Sclerosis Treatment Market Status
5.3 Europe Primary Progressive Multiple Sclerosis Treatment Market Status
5.4 Asia Pacific Primary Progressive Multiple Sclerosis Treatment Market Status
5.5 Central & South America Primary Progressive Multiple Sclerosis Treatment Market Status
5.6 Middle East & Africa Primary Progressive Multiple Sclerosis Treatment Market Status
6 North America Primary Progressive Multiple Sclerosis Treatment Market Status
6.1 North America Primary Progressive Multiple Sclerosis Treatment Market by Country
6.2 United States
6.3 Canada
6.4 Mexico
7 Europe Primary Progressive Multiple Sclerosis Treatment Market Status
7.1 Europe Primary Progressive Multiple Sclerosis Treatment Market by Country
7.2 Germany
7.3 France
7.4 UK
7.5 Italy
7.6 Russia
7.7 Spain
8 Asia Pacific Primary Progressive Multiple Sclerosis Treatment Market Status
8.1 Asia Pacific Primary Progressive Multiple Sclerosis Treatment Market by Country
8.2 China
8.3 Japan
8.4 Korea
8.5 Southeast Asia
8.6 India
8.7 Australasia
9 Central & South America Primary Progressive Multiple Sclerosis Treatment Market Status
9.1 Central & South America Primary Progressive Multiple Sclerosis Treatment Market by Country
9.2 Brazil
9.3 Argentina
9.4 Colombia
10 Middle East & Africa Primary Progressive Multiple Sclerosis Treatment Market Status
10.1 Middle East & Africa Primary Progressive Multiple Sclerosis Treatment Market by Country
10.2 Iran
10.3 Israel
10.4 Turkey
10.5 South Africa
10.8 Saudi Arabia
11 Major Downstream Customers Analysis
11.1 Customer One Analysis
11.2 Customer Two Analysis
11.3 Customer Three Analysis
11.4 Customer Four Analysis
12 Global Primary Progressive Multiple Sclerosis Treatment Market Forecast by Type and by Application
12.1 Global Primary Progressive Multiple Sclerosis Treatment Sales Value Forecast (2022-2027)
12.2 Global Primary Progressive Multiple Sclerosis Treatment Forecast by Type
12.3 Global Primary Progressive Multiple Sclerosis Treatment Forecast by Application
13 Global Primary Progressive Multiple Sclerosis Treatment Market Forecast by Region/Country
13.1 Global Primary Progressive Multiple Sclerosis Treatment Market Forecast by Region (2022-2027)
13.2 North America Market Forecast
13.3 Europe Market Forecast
13.4 Asia Pacific Market Forecast
13.5 Central & South America Market Forecast
13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
14.1 Teva Pharmaceutical Industries Ltd.
14.1.1 Company Information
14.1.2 Primary Progressive Multiple Sclerosis Treatment Product Introduction
14.1.3 Teva Pharmaceutical Industries Ltd. Primary Progressive Multiple Sclerosis Treatment Sales Value, Gross Margin and Global Share (2019-2021)
14.1.4 SWOT Analysis
14.2 Santhera Pharmaceuticals Holding AG
14.2.1 Company Information
14.2.2 Primary Progressive Multiple Sclerosis Treatment Product Introduction
14.2.3 Santhera Pharmaceuticals Holding AG Primary Progressive Multiple Sclerosis Treatment Sales Value, Gross Margin and Global Share (2019-2021)
14.2.4 SWOT Analysis
14.3 MedDay SA
14.3.1 Company Information
14.3.2 Primary Progressive Multiple Sclerosis Treatment Product Introduction
14.3.3 MedDay SA Primary Progressive Multiple Sclerosis Treatment Sales Value, Gross Margin and Global Share (2019-2021)
14.3.4 SWOT Analysis
14.4 Kyorin Pharmaceutical Co., Ltd.
14.4.1 Company Information
14.4.2 Primary Progressive Multiple Sclerosis Treatment Product Introduction
14.4.3 Kyorin Pharmaceutical Co., Ltd. Primary Progressive Multiple Sclerosis Treatment Sales Value, Gross Margin and Global Share (2019-2021)
14.4.4 SWOT Analysis
14.5 Glialogix, Inc.
14.5.1 Company Information
14.5.2 Primary Progressive Multiple Sclerosis Treatment Product Introduction
14.5.3 Glialogix, Inc. Primary Progressive Multiple Sclerosis Treatment Sales Value, Gross Margin and Global Share (2019-2021)
14.5.4 SWOT Analysis
14.6 Genzyme Corporation
14.6.1 Company Information
14.6.2 Primary Progressive Multiple Sclerosis Treatment Product Introduction
14.6.3 Genzyme Corporation Primary Progressive Multiple Sclerosis Treatment Sales Value, Gross Margin and Global Share (2019-2021)
14.6.4 SWOT Analysis
14.7 F. Hoffmann-La Roche Ltd.
14.7.1 Company Information
14.7.2 Primary Progressive Multiple Sclerosis Treatment Product Introduction
14.7.3 F. Hoffmann-La Roche Ltd. Primary Progressive Multiple Sclerosis Treatment Sales Value, Gross Margin and Global Share (2019-2021)
14.7.4 SWOT Analysis
...
15 Conclusion
16 Methodology

List of Figure

List of Tables

Table Global Primary Progressive Multiple Sclerosis Treatment Sales Value (Million USD) and CAGR by Region (2016-2027)
Table Global Primary Progressive Multiple Sclerosis Treatment Sales Value (Million USD) by Company (2019-2021)
Table Global Primary Progressive Multiple Sclerosis Treatment Sales Value Market Share by Company (2019-2021)
Table Main Manufacturers Primary Progressive Multiple Sclerosis Treatment Sales Area
Table Primary Progressive Multiple Sclerosis Treatment Market Concentration (Top 3, Top 5) (2019-2021)
Table Global Primary Progressive Multiple Sclerosis Treatment Sales Value (Million USD) by Type (2016-2021)
Table Global Primary Progressive Multiple Sclerosis Treatment Sals Value Market Share by Type (2016-2021)
Table North America Primary Progressive Multiple Sclerosis Treatment Sales Value (Million USD) by Type (2016-2021)
Table North America Primary Progressive Multiple Sclerosis Treatment Sales Value Market Share by Type (2016-2021)
Table Europe Primary Progressive Multiple Sclerosis Treatment Sales Value (Million USD) by Type (2016-2021)
Table Europe Primary Progressive Multiple Sclerosis Treatment Sales Value Market Share by Type (2016-2021)
Table Asia Pacific Primary Progressive Multiple Sclerosis Treatment Sales Value (Million USD) by Type (2016-2021)
Table Asia Pacific Primary Progressive Multiple Sclerosis Treatment Sales Value Market Share by Type (2016-2021)
Table Central & South America Primary Progressive Multiple Sclerosis Treatment Sales Value (Million USD) by Type (2016-2021)
Table Central & South America Pacific Primary Progressive Multiple Sclerosis Treatment Sales Value Market Share by Type (2016-2021)
Table Middle East & Africa Primary Progressive Multiple Sclerosis Treatment Sales Value (Million USD) by Type (2016-2021)
Table Middle East & Africa Primary Progressive Multiple Sclerosis Treatment Sales Value Market Share by Type (2016-2021)
Table Global Primary Progressive Multiple Sclerosis Treatment Sales Value (Million USD) by Application (2016-2021)
Table Global Primary Progressive Multiple Sclerosis Treatment Value Market Share by Application (2016-2021)
Table North America Primary Progressive Multiple Sclerosis Treatment Sales Value (Million USD) by Application (2016-2021)
Table North America Primary Progressive Multiple Sclerosis Treatment Sales Value Market Share by Application (2016-2021)
Table Europe Primary Progressive Multiple Sclerosis Treatment Sales Value (Million USD) by Application (2016-2021)
Table Europe Primary Progressive Multiple Sclerosis Treatment Sales Value Market Share by Application (2016-2021)
Table Asia Pacific Primary Progressive Multiple Sclerosis Treatment Sales Value (Million USD) by Application (2016-2021)
Table Asia Pacific Primary Progressive Multiple Sclerosis Treatment Sales Value Market Share by Application (2016-2021)
Table Central & South America Primary Progressive Multiple Sclerosis Treatment Sales Value (Million USD) by Application (2016-2021)
Table Central & South America Pacific Primary Progressive Multiple Sclerosis Treatment Sales Value Market Share by Application (2016-2021)
Table Middle East & Africa Primary Progressive Multiple Sclerosis Treatment Sales Value (Million USD) by Application (2016-2021)
Table Middle East & Africa Primary Progressive Multiple Sclerosis Treatment Sales Value Market Share by Application (2016-2021)
Table Global Primary Progressive Multiple Sclerosis Treatment Sales Value (Million USD) by Region (2016-2021)
Table Global Primary Progressive Multiple Sclerosis Treatment Value Market Share by Region (2016-2021)
Table North America Primary Progressive Multiple Sclerosis Treatment Sales Value (Million USD) by Country (2016-2021)
Table North America Primary Progressive Multiple Sclerosis Treatment Value Market Share by Country (2016-2021)
Table Europe Primary Progressive Multiple Sclerosis Treatment Sales Value (Million USD) by Country (2016-2021)
Table Europe Primary Progressive Multiple Sclerosis Treatment Value Market Share by Country (2016-2021)
Table Asia Pacific Primary Progressive Multiple Sclerosis Treatment Sales Value (Million USD) by Country (2016-2021)
Table Asia Pacific Primary Progressive Multiple Sclerosis Treatment Value Market Share by Country (2016-2021)
Table Central & South America Primary Progressive Multiple Sclerosis Treatment Sales Value (Million USD) by Country (2016-2021)
Table Central & South America Primary Progressive Multiple Sclerosis Treatment Value Market Share by Country (2016-2021)
Table Middle East & Africa Primary Progressive Multiple Sclerosis Treatment Sales Value (Million USD) by Country (2016-2021)
Table Middle East & Africa Primary Progressive Multiple Sclerosis Treatment Value Market Share by Country (2016-2021)
Table Global Primary Progressive Multiple Sclerosis Treatment Value (Million USD) Forecast by Type (2022-2027)
Table Global Primary Progressive Multiple Sclerosis Treatment Value Market Share Forecast by Type (2022-2027)
Table Global Primary Progressive Multiple Sclerosis Treatment Value (Million USD) Forecast by Application (2022-2027)
Table Global Primary Progressive Multiple Sclerosis Treatment Value Market Share Forecast by Application (2022-2027)
Table Global Primary Progressive Multiple Sclerosis Treatment Value (Million USD) Forecast by Region (2022-2027)
Table Global Primary Progressive Multiple Sclerosis Treatment Value Market Share Forecast by Region (2022-2027)
Table Teva Pharmaceutical Industries Ltd. Company Information
Table Teva Pharmaceutical Industries Ltd. Product Introduction
Table Teva Pharmaceutical Industries Ltd. Primary Progressive Multiple Sclerosis Treatment Sales Value, Gross Margin and Global Share (2019-2021)
Table Santhera Pharmaceuticals Holding AG Company Information
Table Santhera Pharmaceuticals Holding AG Product Introduction
Table Santhera Pharmaceuticals Holding AG Primary Progressive Multiple Sclerosis Treatment Sales Value, Gross Margin and Global Share (2019-2021)
Table MedDay SA Company Information
Table MedDay SA Product Introduction
Table MedDay SA Primary Progressive Multiple Sclerosis Treatment Sales Value, Gross Margin and Global Share (2019-2021)
Table Kyorin Pharmaceutical Co., Ltd. Company Information
Table Kyorin Pharmaceutical Co., Ltd. Product Introduction
Table Kyorin Pharmaceutical Co., Ltd. Primary Progressive Multiple Sclerosis Treatment Sales Value, Gross Margin and Global Share (2019-2021)
Table Glialogix, Inc. Company Information
Table Glialogix, Inc. Product Introduction
Table Glialogix, Inc. Primary Progressive Multiple Sclerosis Treatment Sales Value, Gross Margin and Global Share (2019-2021)
Table Genzyme Corporation Company Information
Table Genzyme Corporation Product Introduction
Table Genzyme Corporation Primary Progressive Multiple Sclerosis Treatment Sales Value, Gross Margin and Global Share (2019-2021)
Table F. Hoffmann-La Roche Ltd. Company Information
Table F. Hoffmann-La Roche Ltd. Product Introduction
Table F. Hoffmann-La Roche Ltd. Primary Progressive Multiple Sclerosis Treatment Sales Value, Gross Margin and Global Share (2019-2021)